Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old
- Conditions
- Decision AidHpv
- Interventions
- Behavioral: ControlBehavioral: Patient decision aid
- Registration Number
- NCT06435338
- Brief Summary
The goal of this study is to learn if a patient decision tool for HPV vaccination works for decision-making among adults ages 27-45. Researchers will compare a web-based patient decision tool to an information sheet to see if the tool works for decision-making. Participants will take a baseline survey, view the intervention or control condition, and then take a follow-up survey.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 632
- Unvaccinated for HPV
- 27-45 years
- Resides in the United States
- Reads English
- Consents to participate
- none
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Control Vaccine information sheet on HPV vaccination view on webpage. Patient decision aid Patient decision aid Patient decision aid on HPV vaccination on webpage.
- Primary Outcome Measures
Name Time Method Decisional conflict - 16 item scale Immediate post-test This scale has 16 items and 5 response categories. The decisional conflict scale (DCS) measures personal perceptions of: uncertainty in choosing options; modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making; and effective decision making (in full version) such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice. The scores ranged from 0 "no conflict" to 100 "extreme decisional conflict."
Decisional conflict - 4 item scale Immediate post-test Decision conflict scale recommended for every day clinical practice. It has 4 items and two response categories. Scores range from 0 \[extremely high decisional conflict\] to 4 \[no decisional conflict\].
- Secondary Outcome Measures
Name Time Method Knowledge Immediate post-test 16-item knowledge item related to human papillomavirus and human papillomavirus vaccination. Scale from 0 \[low knowledge\] to 16 \[high knowledge\].
Perceived expectation Immediate post-test Perceived expectation was assessed by asking participant agreement on a 5-point Likert scale to the following statement, "The effectiveness of the HPV vaccine will vary from person to person." Higher score indicates higher perceived effectiveness.
Intentions Immediate post-test Intentions for information seeking, talking to a healthcare provider, and getting vaccinated
Decision self-efficacy Immediate post-test The Decision Self-Efficacy Scale evaluates an individual's self-confidence to make decisions on their own or with support from other sources. Scores range from 0 \[extremely low self-efficacy\] to 100 \[extremely high self efficacy\].
Perceived risk Immediate post-test Perceived risks of HPV infection were also assessed, including participants' perceptions of getting an HPV-associated infection genital/anal warts, or cancer in their lifetime. Response options ranged from very unlikely (lower score) to very likely (higher score).
How likely are you to get an HPV related cancer, like cervical, oral, or anal cancer, in your lifetime? How likely are you to get an HPV infection in your lifetime? How likely are you to get anal or genital warts in your lifetime?Decision Immediate post-test Vaccine decision, including decide to get vaccinated, unsure, and decided not to get vaccinated
Trial Locations
- Locations (1)
UT School of Public Health San Antonio
🇺🇸San Antonio, Texas, United States